Larry Eastland purchased control of this shell around the end of March 2022 (11,866,563 shares).
Since my last post over on the ADMG board, I have been adding to my position at prices under 13 cents. Picked up a 50K block at ten cents today. My current cost basis is now under 12.9 cents.
Over on the ADMG board I mentioned that Eastland had registered a biotech advisory service company in Florida during 2021. I speculated that maybe he might use the ADMG shell for some type of biotech RM. Kind of interesting to note that after I made that post the quarterly filing for TGRP (another company/shell that Eastland was connected with during 2021 before selling it to another party in Asia/Australia ) disclosed that it had been purchased by James Talton. It seems highly likely to me that Eastland had a role in James Talton buying control of that shell. I don't think it is just merely a coincidence that Talton owns a biotech business located in the same city where Eastland established his biotech advisory company.
Perhaps worth noting: TGRP's legacy share valuation at its current bid price is over $11M, and at its current ask price TGRP's legacy valuation is over $21M. Also perhaps worth noting: In the TGRP situation all of the Eastland associated shares were ultimately sold to the new control person. If a similar scenario (structure/price) occurred with this ADMG shell, that would be the equivalent of ADMG trading at a price over $2.5 per share.